Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-13
2005-12-13
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S259500, C544S279000, C544S281000
Reexamination Certificate
active
06974819
ABSTRACT:
Imidazo[1,2-α]pyrimidinones and pyrimido[1,2-α]pyrimidinones useful for preventive and/or therapeutic treatment of neurodegenerative diseases, such as Alzheimer's disease, caused by abnormal GSK3β activity.
REFERENCES:
patent: WO 00/18758 (2000-04-01), None
Wagman AS, Johnson KW, Bussiere DE., Curr Pharm Des. 2004;10(10):1105-37.
Alonso M, Martinez A., Curr Med Chem. Mar. 2004;11(6):755-63.
Eldar-Finkelman H, Ilouz R., Expert Opin Investig Drugs. Sep. 2003;12(9):1511-9.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Almario Garcia Antonio
Gallet Thierry
Li Adrien Tak
Lochead Alistair
Marguerie Séverine
Alexander Michael
Bender Kelly
Dupont Paul
McKenzie Thomas C.
Mitsubishi Pharma Corporation
LandOfFree
2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520586